Showing results (81-90 of 148) with videos related to
Sort By:
Pageof 15
Transplantation Direct|July 8, 2026
Enhanced Peribiliary Gland Detachment in Aged Donor Grafts After Rat Liver TransplantationKaoru Katano, Shinichi Nakanuma, Takashi Sugio, et al.American Journal of Cancer Research|July 12, 2021
Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factorsHiroki Matsukawa, Noriho Iida, Kazuya Kitamura, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[A Case of Stage ⅣRectal Cancer with Dyskeratosis Congenita]Keishi Nakamura, Shiro Terai, Yoshinao Ohbatake, et al.Transplantation Proceedings|August 3, 2023
Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case ReportShinichi Nakanuma, Ryosuke Gabata, Mitsuyoshi Okazaki, et al.Anticancer Research|December 27, 2017
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-paclitaxel Reduces the Number of Cancer-associated Fibroblasts Through Depletion of Pancreatic StromaTomoharu Miyashita, Hidehiro Tajima, Isamu Makino, et al.Digestive Diseases and Sciences|December 10, 2013
Sivelestat sodium hydrate inhibits neutrophil migration to the vessel wall and suppresses hepatic ischemia-reperfusion injurySeisho Sakai, Hidehiro Tajima, Tomoharu Miyashita, et al.Clinical and Experimental Medicine|October 10, 2015
Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancerTomoharu Miyashita, Kenji Miki, Takashi Kamigaki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 30, 2019
[A Case of Pathological Complete Response Induced by Preoperative Chemotherapy with Gemcitabine plus Nab-Paclitaxel in a Patient with Pancreatic Cancer on Hemodialysis]Mitsuyoshi Okazaki, Hidehiro Tajima, Yoshinao Ohbatake, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation]Yuto Kitano, Jun Kinoshita, Katsunobu Oyama, et al.International Journal of Oncology|April 4, 2012
Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinomaMasatoshi Shoji, Itasu Ninomiya, Isamu Makino, et al.Pageof 15